Ferreira MHQ, Ribeiro RMP, Funes ABA, Faustino BMO, Segato FC, Mattos LLC de, et al. Therapeutic action of the evolocumab monoclonal antibody against PCSK9 proteins in LDL cholesterol modulation: systematic review. Rev. Atenção Saúde [Internet]. 2017 Aug. 17 [cited 2026 Jan. 23];15(52):72-7. Available from: https://www.seer.uscs.edu.br/index.php/revista_ciencias_saude/article/view/4439